Doctor please tell me what is best for me and my baby

References

• Michaud CM, Murray CJ, Bloom BR. Burden of disease: implications for future research. JAMA285, 535–539 (2000).
   Google Scholar
• Judd LL, Akiskal HS, Maser JD et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch. Gen. Psychiatry55, 694–700 (1998).
   PubMed Web of Science ®Google Scholar
• Halbreich U. Prevalence of mood symptoms and depression during pregnancy: implications for clinical practice and research. CNS Spectr.9(3), 177–184 (2004).
   PubMed Web of Science ®Google Scholar
• Bennett HA, Einarson AE, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet. Gynecol.103, 698–709 (2004).
   PubMed Web of Science ®Google Scholar
• Zuckerman B, Amaro H, Bauchner H, Cabral H. Depressive symptoms during pregnancy: relationship to poor health behaviours. Am. J. Obstet. Gynecol.160, 1107–1111 (1989).
   PubMed Web of Science ®Google Scholar
• Steer R, Scholl T, Hediger M, Fischer R. Self-reported depression and negative pregnancy outcomes. J. Clin. Epidemiol.45, 1093–1099 (1992).
   PubMed Web of Science ®Google Scholar
• Orr S, Miller C. Maternal depressive symptoms and the risk of poor pregnancy outcomes. Review of the literature and preliminary findings. Epidemiol. Rev.17, 165–171 (1995).
   PubMed Web of Science ®Google Scholar
• Martins C, Gaffin EA. Effects of early maternal depression on patterns of infant–mother attachment: a meta-analytic investigation. J. Child Psychol. Psychiatry41, 737–746 (2000).
   PubMed Web of Science ®Google Scholar
• Zuckerman B, Bauchner H, Parker S, Cabral H. Maternal depressive symptoms during pregnancy, and newborn irritability. J. Dev. Behav. Pediatr.11, 190–194 (1990).
   PubMed Web of Science ®Google Scholar
• Nulman I, Rovet J, Stewart DE et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am. J. Psychiatry159(11), 1889–1895 (2002).
   PubMed Web of Science ®Google Scholar
• Weinberg MK, Tronick EZ. The impact of maternal psychiatric illness on infant development. J. Clin. Psychiatry59(Suppl. 2), 53–61 (1998).
   PubMed Web of Science ®Google Scholar
• Hammen C, Brennan PA. Severity, chronicity, and timing of maternal depression and risk for adolescent offspring diagnoses in a community sample. Arch. Gen. Psychiatry60, 253–258 (2003).
   PubMed Web of Science ®Google Scholar
• Spinelli MG, Endicott J. Controlled trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women. Am. J. Psychiatry160, 555–562 (2003).
   PubMed Web of Science ®Google Scholar
• Spinelli MG. Interpersonal psychotherapy for depressed antepartum women: a pilot study. Am. J. Psychiatry154, 1028–1030 (1997).
   PubMed Web of Science ®Google Scholar
• Misri S, Kendrick K. Treatment of perinatal mood and anxiety disorders: a review. Can. J. Psychiatry52, 489–498 (2007).
   PubMed Web of Science ®Google Scholar
• Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch. Pediatr. Adolesc. Med.160, 173–176 (2006).
   PubMed Web of Science ®Google Scholar
• Chambers CD, Hernandez-Diaz S, Van Marter LJ et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N. Engl. J. Med.354, 579–587 (2006).
   PubMed Web of Science ®Google Scholar
• Kallen B, Otterblad Olausson P. Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod. Toxicol.21(3), 221–222 (2006).
   PubMed Web of Science ®Google Scholar
• Berard A, Ramos E, Rey E et al. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res. B Dev. Reprod. Toxicol.80, 18–27 (2007).
   PubMed Web of Science ®Google Scholar
• Wogelius P, Norgaard M, Gislum M et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology17(6), 701–704 (2006).
   PubMed Web of Science ®Google Scholar
• Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet. Gynecol.106(6), 1289–1296 (2005).
   PubMed Web of Science ®Google Scholar
• Wen SW, Yang Q, Garner P et al. Selective serotonin reuptake inhibiting and adverse pregnancy outcomes. Am. J. Obstet. Gynecol.194(4), 961–966 (2006).
   PubMed Web of Science ®Google Scholar
• Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM; National Birth Defects Prevention Study. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N. Engl. J. Med.356(26), 2684–2692 (2007).
   PubMed Web of Science ®Google Scholar
• Louik C, Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth. N. Engl. J. Med.356(26), 2675–2683 (2007).
   PubMed Web of Science ®Google Scholar
• Kallen BAJ, Olausson PO. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res. Part A Clin. Mol. Teratol.79, 301–308 (2007).
   PubMed Web of Science ®Google Scholar
• Pearson KH, Nonacs RM, Viguera AC et al. Birth outcomes following prenatal exposure to antidepressants. J. Clin. Psychiatry68, 1277–1279 (2007).
   PubMedGoogle Scholar
• Addis A, Koren G. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychol. Med.30, 89–94 (2000).
   PubMed Web of Science ®Google Scholar
• Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malfunctions: a meta-analysis of prospective comparative studies. Pharmacoepidemiol. Drug Saf.14(12), 823–827 (2005).
   PubMed Web of Science ®Google Scholar
• Cohen LS, Altshuler LL, Harlow BL et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA295, 499–507 (2006).
   PubMed Web of Science ®Google Scholar
• Oates M. Perinatal psychiatric disorders: a leading cause of maternal morbidity and mortality. Br. Med. Bull.67, 219–229 (2003).
   PubMed Web of Science ®Google Scholar